GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Clover Corp Ltd (ASX:CLV) » Definitions » ROCE %

Clover (ASX:CLV) ROCE % : -0.58% (As of Jan. 2024)


View and export this data going back to 1999. Start your Free Trial

What is Clover ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Clover's annualized ROCE % for the quarter that ended in Jan. 2024 was -0.58%.


Clover ROCE % Historical Data

The historical data trend for Clover's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Clover ROCE % Chart

Clover Annual Data
Trend Jul14 Jul15 Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22 Jul23
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 28.85 28.56 12.13 14.27 12.02

Clover Semi-Annual Data
Jul14 Jan15 Jul15 Jan16 Jul16 Jan17 Jul17 Jan18 Jul18 Jan19 Jul19 Jan20 Jul20 Jan21 Jul21 Jan22 Jul22 Jan23 Jul23 Jan24
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.51 20.18 14.57 9.51 -0.58

Clover ROCE % Calculation

Clover's annualized ROCE % for the fiscal year that ended in Jul. 2023 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Jul. 2023 )  (A: Jul. 2022 )(A: Jul. 2023 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Jul. 2023 )  (A: Jul. 2022 )(A: Jul. 2023 )
=9.091/( ( (90.604 - 17.247) + (86.202 - 8.289) )/ 2 )
=9.091/( (73.357+77.913)/ 2 )
=9.091/75.635
=12.02 %

Clover's ROCE % of for the quarter that ended in Jan. 2024 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Jan. 2024 )  (Q: Jul. 2023 )(Q: Jan. 2024 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Jan. 2024 )  (Q: Jul. 2023 )(Q: Jan. 2024 )
=-0.452/( ( (86.202 - 8.289) + (84.87 - 6.502) )/ 2 )
=-0.452/( ( 77.913 + 78.368 )/ 2 )
=-0.452/78.1405
=-0.58 %

(1) Note: The EBIT data used here is two times the semi-annual (Jan. 2024) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Clover  (ASX:CLV) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.


Clover ROCE % Related Terms

Thank you for viewing the detailed overview of Clover's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Clover (ASX:CLV) Business Description

Traded in Other Exchanges
N/A
Address
39 Pinnacle Road, Altona North, Melbourne, VIC, AUS, 3025
Clover Corp Ltd provides nutritional and functional ingredients. The company is involved in the production of encapsulated powders, and research and product development of functional food and infant nutrition ingredients. It offers Nu-Mega Hi docosahexaenoic acid tuna oils for use in infant formula and pharmaceutical products; and Ocean Gold refined tuna oils. Its products include DHA oils, DHA powders, and Microencapsulation. Geographically, the group has a business presence in Australia, New Zealand, Asia, Europe, and the Americas. Majority of the revenue is derived from Asia.